Program Highlights 2019

Main Topics

  • Clinical Trials
  • Artificial Intelligence in Healthcare
  • New Findings of Drug Actions / Repurposing
  • Investment Models from around the the Globe


Confirmed Speakers

  • Arthur L. Caplan, PhD, Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, New York,  US  
  • Evan Castiglia, Senior Associate, Philips Health Technology Ventures, Amsterdam, NL
  • Eyal Gura, Co-Founder & CEO, Zebra Medical, Israel
  • Michael Hemann, PHD , MIT Koch Institute for Integrated Cancer Research, Associate Professor of Biology, Cambridge, MA, US
  • Vincent Hennemand, VP, Strategy, Corporate and Business Development, Head of Immuno-Inflammation Program Unit Akili Interactive Labs, Boston, MA, US 
  • Gottfried Ludewig, Dr., Head of the Department for Digitization of Health Care at the Federal Ministry of Health, Berlin, DE
  • Mark H. Michalski, MD, Executive Director MGH & BWH Center for Clinical Data Science Harvard Medical School, Boston, MA, US 
  • Deborah Wake, CEO and Chief Medical Officer, MyWay Digital Health, Dundee, UK 

Program and speakers are subject to change without notice.